- Research article
- Open Access
Conservation of the glucan phosphatase laforin is linked to rates of molecular evolution and the glucan metabolism of the organism
BMC Evolutionary Biology volume 9, Article number: 138 (2009)
Lafora disease (LD) is a fatal autosomal recessive neurodegenerative disease. A hallmark of LD is cytoplasmic accumulation of insoluble glucans, called Lafora bodies (LBs). Mutations in the gene encoding the phosphatase laforin account for ~50% of LD cases, and this gene is conserved in all vertebrates. We recently demonstrated that laforin is the founding member of a unique class of phosphatases that dephosphorylate glucans.
Herein, we identify laforin orthologs in a protist and two invertebrate genomes, and report that laforin is absent in the vast majority of protozoan genomes and it is lacking in all other invertebrate genomes sequenced to date. We biochemically characterized recombinant proteins from the sea anemone Nematostella vectensis and the amphioxus Branchiostoma floridae to demonstrate that they are laforin orthologs. We demonstrate that the laforin gene has a unique evolutionary lineage; it is conserved in all vertebrates, a subclass of protists that metabolize insoluble glucans resembling LBs, and two invertebrates. We analyzed the intron-exon boundaries of the laforin genes in each organism and determine, based on recently published reports describing rates of molecular evolution in Branchiostoma and Nematostella, that the conservation of laforin is linked to the molecular rate of evolution and the glucan metabolism of an organism.
Our results alter the existing view of glucan phosphorylation/dephosphorylation and strongly suggest that glucan phosphorylation is a multi-Kingdom regulatory mechanism, encompassing at least some invertebrates. These results establish boundaries concerning which organisms contain laforin. Laforin is conserved in all vertebrates, it has been lost in the vast majority of lower organisms, and yet it is an ancient gene that is conserved in a subset of protists and invertebrates that have undergone slower rates of molecular evolution and/or metabolize a carbohydrate similar to LBs. Thus, the laforin gene holds a unique place in evolutionary biology and has yielded insights into glucan metabolism and the molecular etiology of Lafora disease.
Lafora disease (LD; OMIM 254780) is an autosomal recessive neurodegenerative disorder. It is one of five major progressive myoclonus epilepsies (PMEs) . LD commonly presents as a single seizure in the second decade of the patient's life, followed by progressive central nervous system degeneration, intellectual decline, and death within ten years of the first seizure [2–4]. LD is unique among the PMEs because of the patient's rapid neurological deterioration and the accumulation of insoluble glucans/carbohydrates called Lafora bodies (LB) [5, 6].
While animals normally store glucans as soluble glycogen, LBs are accumulations of poorly branched, hyperphosphorylated, insoluble glucans and are not glycogen. Forty years ago, Sakai and co-workers biochemically characterized LBs and found that they more closely resemble plant starch than glycogen [6–8]. Although LBs are found in the cytoplasm of most cells, cell death only occurs in neurons . LD patients exhibit increased neuronal cell death, number of seizures, and LB accumulation as they age; thus, it is hypothesized that LBs trigger these symptoms and ultimately the death of the patient .
EPM2A (epilepsy of progressive myoclonus type 2) is mutated in ~50% LD cases [9, 10]. EPM2A encodes a protein named laforin that contains a carbohydrate binding module (CBM) followed by the canonical dual specificity phosphatase (DSP) active site motif, HCXXGXXRS/T (Cx5R) [9, 11] (Fig. 1A). Accordingly, recombinant laforin binds glucans, in vitro and in vivo, and it possesses phosphatase activity in vitro [12, 13]. Out of ~130 human phosphatases laforin is the only phosphatase with a CBM. While data placed laforin in the context of being intimately, if not directly, involved in glycogen metabolism, the molecular etiology of LD was unknown for almost 100 years.
We recently demonstrated that laforin is not restricted to vertebrate genomes, as originally thought , but that laforin orthologs are present in five protists (i.e. single-cell eukaryotes) . Each of these five protists undergoes hibernation during their life cycle and when they hibernate they generate an insoluble glucan as an energy source [16–18]. We recognized that the glucan produced by these protists are biochemically similar to Lafora bodies and proposed that laforin functions to convert insoluble glucans into energy, and in vertebrates it functions to inhibit insoluble glucan accumulation (i.e. LBs) .
To test this hypothesis, we utilized a recently characterized gene in Arabidopsis called s tarch ex cess 4 (SEX4) [19, 20]. SEX4 encodes a protein with similar domains as laforin but in the opposite orientation (Fig. 1B). Disruption of SEX4 leads to increased accumulation of insoluble glucans (i.e. starch), a cellular phenotype reminiscent of LD patients . We found that when laforin was targeted to the chloroplast of sex4-deficient plants that it rescued the sex4 mutant phenotype. Demonstrating that laforin and SEX4 are functional equivalents and that a laforin-like activity is required to regulate the metabolism of insoluble glucans in multiple Kingdoms .
We also demonstrated the nature of this activity; we showed that laforin and SEX4 dephosphorylate the glucan itself [15, 21, 22]. Thus, we proposed that when laforin is absent, phosphates accumulate in glycogen precursors, branching is inhibited, and Lafora bodies form. This prediction was supported by work published 40 years ago showing LBs from human patients are poorly branched and contain 4–5 fold more phosphate than glycogen, and further corroborated by data from the Roach lab confirming these results in a LD mouse model [23, 24]. Therefore, laforin regulates an overlooked aspect of glycogen metabolism in vertebrates by removing phosphate from glycans during glycogen synthesis.
Herein, we establish definitive boundaries concerning the evolutionary conservation of laforin by probing more than 210 eukaryotic genomes. We utilized criteria that we previously defined to correctly predict a laforin ortholog in the genome of the protozoan Neospora caninum. In addition, we extend our previous results by uncovering putative laforin orthologs in two invertebrates, Nematostella vectensis and Branchiostoma floridae. We cloned the respective genes and biochemically verified that they are laforin orthologs. Furthermore, we present evidence and hypothesize why laforin is conserved in these two invertebrates and is absent in all others sequenced to date. Cumulatively, these results demonstrate that the glucan phosphatase laforin is conserved in a subset of eukaryotic organisms from an array of evolutionary niches, vertebrates, invertebrates, and protists, and highlights the fundamental importance of glucan phosphorylation/dephosphorylation.
Results and discussion
Carbohydrate binding modules (CBMs) are domains typically found in glucosylhydrolases and glucotransferases in bacterial, fungal, or plant genomes [25–27]. The vast majority of enzymes containing CBMs utilize the domain to bind a specific glucan and enzymatically act on the sugar, as in the case of α-amylase . Accordingly, we recently demonstrated, and others confirmed, that laforin and SEX4 bind and dephosphorylate glucans, glycogen and starch, respectively [15, 21, 23, 24]. While laforin and SEX4 bind similar types of glucans, they utilize evolutionarily distinct CBMs . CBMs are classified into fifty-three evolutionarily distinct families, based on primary sequence, secondary and tertiary predictions, and crystal structures . Laforin contains an amino-terminal CBM20 and SEX4 a carboxy-terminal CBM21 type CBM (Fig. 1A &1B). Although laforin and SEX4 have evolutionarily distinct CBMs, multiple groups have proposed that CBM20 and CBM21 may share a common evolutionary origin and suggest keeping distinct families grouped into a common CBM clan [28–31].
Confirmation of laforin predictions
Previously we reported that out of 170 eukaryotic genomes (including 94 protozoan) and 670 bacterial genomes that the laforin gene is only conserved in vertebrate genomes and in five protozoan genomes, Toxoplasma gondii, Eimeria tenella, Tetrahymena thermophila, Paramecium tetraurelia, and Cyanidioschyzon merolae  (Fig. 1C). In addition, we demonstrated that SEX4 is conserved in green algae and land plants (collectively known as Archaeplastida/Kingdom Plantae) and showed that while laforin and SEX4 are not orthologous proteins that they are functional equivalents  (Fig. 1C). Our phylogenetic analyses and examination of the biology and evolution of the five protists that have laforin led us to propose three criteria to predict if a protozoan genome would contain laforin: the organism must 1) be of red algal descent, 2) possess a true mitochondrion, and 3) produce an insoluble glucan (e.g. floridean starch, amylopectin granules, etc.) . Out of the 170 organisms that we probed, we found that if an organism lacked one of these qualities then it lacked laforin and if it possessed all of these qualities then it possessed laforin . Therefore, Plasmodium species lack laforin because they do not metabolize insoluble glucans, Cryptosporidium species lack laforin because they lack true mitochondria, and Chlamydomonas lack laforin because they are not of red-algal descent (and instead have SEX4) . Some of the genomes that we originally probed were incomplete at the time. However, based on the above three criteria, we postulated that the following four organisms currently being sequenced would contain laforin, Galdieria sulphuraria, Guillardia theta, Neospora caninum, and Sarcocystis neurona .
In light of the relatedness between CBM20 and CBM21 CBMs, we probed 122 protozoan genomes (28 more than previously) searching for a protein containing a CBM20 or CBM21 domain followed by a phosphatase domain. In order to enhance our likelihood of uncovering a laforin ortholog, we performed BLASTp and tBLASTn searches of multiple databases (Additional File 1) using human (Hs-) and C. merolae (Cm-) laforin, as C. merolae is likely the most evolutionarily ancient organism with laforin and Cm-laforin was the least identical (25%) to Hs-laforin of all the protozoan laforin orthologs previously identified . To ensure that we did not miss a laforin-like protein in these genomes, we also searched the same databases using the same search methods for proteins with a DSP domain followed by a CBM20 or CBM21, i.e. SEX4 orthologs.
The only novel putative laforin ortholog that we uncovered was in the genome of Neospora caninum, a genome we predicted would contain laforin  (Fig. 2A). N. caninum laforin (Nc-laforin) was only16% and 23% similar to Cm- and Hs-laforin, respectively (Fig. 2B). As we predicted, N. caninum fulfils our three criteria in that it is of red algal descent, possesses true mitochondria, and generates insoluble starch in the form of amylopectin granules [32–35]. N. caninum is classified as an alveolate and is a parasite of canines . N. caninum structurally resembles T. gondii to such a degree that it was not properly identified until 1988 . Therefore, we aligned the putative Nc-laforin with T. gondii (Tg)-laforin and found that these proteins are 82% identical (Fig. 2). In addition, all of the residues known to be necessary for glucan binding and phosphatase activity in Tg-laforin are conserved in Nc-laforin (Fig. 2A). Furthermore, the predicted secondary structure of Nc-laforin and Tg-laforin are identical and both are very similar to Hs-laforin (Fig. 2A). Given the degree of similarity between Nc- and Tg-laforin at the primary and secondary amino acid level and the fact that we previously cloned and characterized Tg-laforin , Nc-laforin is a laforin ortholog. This finding confirms the predictive power of our three criteria in predicting the absence or presence of laforin in protozoan genomes. We did not uncover a laforin ortholog in the genomes of G. sulphuraria, G. theta, or S. neurona, but their nuclear genomes are not complete and we still predict that they do contain laforin.
Discovery of putative laforin orthologs in invertebrate genomes
Metazoans are defined as all living animals that contain tissues and are descended from the last common ancestor of Bilateria, Cnidaria (jellyfish, sea anemones, corals, hydra, etc.), Ctenophora (comb jellies), Placozoa (Trichoplax sp.), and Porifera (sponges) . Bilateralians are subdivided as either protostomes (including arthropods, nematodes, annelids, and mollusks) or deuterostomes. The three major deuterstome phyla, chordates, echinoderms (sea urchins, sea stars, etc.), and hemichordates (acorn worm), arose from a common ancestor more than 600 million years ago, followed by subsequent divergence of the chordates into three subphyla: cephalochordates, urochordates (also called tunicates), and vertebrates (summarized in Additional File 2) [39, 40].
The gene encoding laforin is an evolutionarily ancient gene, originating in a primitive red alga, or its ancestor, long before the emergence of metazoans . While laforin is an ancient gene, it has a unique evolutionary lineage. Although we previously identified laforin orthologs in five protozoan genomes, we did not find it in any non-vertebrate model organism genomes (yeast, fly, or worms), nor did we find it in the genome of any invertebrates . We postulated that invertebrates lack laforin because they do not synthesize an insoluble glucan as an energy source (as do the protozoans that contain laforin) and they do not inhibit insoluble glucan accumulation (as seen with vertebrates inhibiting LBs). However, over the course of the last two years multiple basal position metazoan genomes have been sequenced or improved and a surplus of information has been gleaned by the evo-devo community from the genomes of Branchiostoma floridae (commonly known as amphioxus, subphylum cephalochordata), Ciona intestinalis (sea squirt belonging to urochordates), Monosiga brevicollis (choanoflagellate and closest known unicellular relative to metazoans), Nematostella vectensis (sea anemone belonging to the ancient metazoan Phylum Cnidaria), and Trichoplax adhaerens (arguably the simplest free-living metazoan, Phylum Placozoa) [41–45]. While definitive conclusions concerning the origin and early radiation of these organisms in the metazoan tree of life remain unsettled, these reports have elucidated multiple aspects of metazoan evolution and the genomes of primitive metazoans regarding genome complexity, exon-intron structure, gene repertoire, and rates of molecular evolution.
Given these recent advances we performed searches as described above searching multiple databases (Additional File 1) for putative laforin orthologs in the genome of 212 eukaryotes (including the 122 protozoan). We identified putative laforin orthologs in the genome of two invertebrates, the cnidarian sea anemone Nematostella vectensis and the small worm-like urochordate Branchiostoma floridae (Fig. 3A). The putative N. vectensis laforin (Nv-laforin) is 44% identical to Hs-laforin and contains all but one of the known residues conferring glucan binding and phosphatase activity (Fig. 3A &3B). In the B. floridae genome we discovered three open reading frames that each encoded a putative laforin ortholog (Fig. 3A). The putative B. floridae laforin (Bf-laforin) orthologs are 29–41% identical to Hs-laforin and share the majority of residues important for glucan binding and phosphatase activity (Fig. 3A &3B). In addition, all four genes encode proteins that have very similar predicted secondary structure to Hs-laforin (Fig. 3A). The predicted secondary structure of the CBM of Nv-laforin and the Bf-laforins are nearly identical with Hs-laforin, but have a predicted helix in place of a coil-coil (Fig. 3A). All four proteins contain the predicted five β-sheets and six α-helices typical of a dual specificity phosphatase domain and are identical with Hs-laforin (Fig. 3A).
To gain insight into the evolution of these putative laforin orthologs, we analyzed the gene structure and intron-exon boundaries of each and compared them with the gene encoding Hs-laforin, EPM2A. EPM2A is comprised of four exons and three introns (Fig. 3C) [9, 10]. Similarly, Bf-laforin-264244 has the same arrangement and the intron-exon boundaries are at similar locations (Fig. 3C). The other two putative Bf-laforin orthologs each contain three exons and two introns. Additionally, exon 1 from these two Bf-laforins is similar in size to exon 1 and exon 2 of both Hs-laforin and Bf-laforin-264244, suggesting possible intron loss (Fig. 3C). Finally, Nv-laforin has no introns, suggesting intron loss and potentially an increased rate of evolution at this locus in Nematostella.
Accelerated rates of evolution occur in echinoderms, fruit flies, nematodes, and the sea squirt C. intestinalis [40, 46–48]. These accelerated rates of evolution result in amino acid substitution, intron loss, gene loss, and genome rearrangement. Surprisingly, recent studies show that the genomes of Nematostella and Branchiostoma have evolved at a rate comparable to or slower than vertebrates [42–44]. These studies generated phylogenies derived from 104 , 337 , and 1090  single-copy nuclear encoded genes to estimate rates of molecular evolution. Their phylogenies showed long branch lengths, indicating increased sequence divergence, for the genomes of all organisms investigated except vertebrates, Nematostella, and Branchiostoma [42–44]. Thus, they concluded that the genomes of the fly, hydra, nematode, yeast, sea squirt, sponge, snail, and the choanoflagellate M. brevicollis have evolved at a more rapid rate (summarized in Table 1). In addition to primary sequence comparison, these studies also examined the conservation of introns in various species and found that in alignable regions the genomes of Nematostella and Branchiostoma share >80% of human introns [42, 44]. Conversely, D. melanogaster, C. elegans, and C. intestinalis have lost 50–90% of the inferred ancestral metazoan introns [42, 44] (summarized in Table 1). Thus, it is proposed that ancient metazoan genomes more closely resembled the complexity seen in the human genome rather than that observed in yeast, flies, or worms [42–45, 49].
The laforin gene in H. sapiens, T. gondii, N. caninum, E. tenella, P. tetraurelia, and B. floridae all contain at least four exons. Therefore, we propose that the laforin gene originally had four or more exons, and that the introns were lost in C. merolae and Nematostella. These results suggest that the laforin gene locus underwent a higher rate of molecular evolution than genes in Nematostella that share conserved introns with human genes. This increased molecular evolution may explain the absence of laforin in yeast, flies, worms, and the majority of invertebrates as we discuss below.
Biochemical characterization of Nv- and Bf-laforin
To determine if we had identified true laforin orthologs in invertebrates, we cloned the genes expressing Nv-laforin and Bf-laforin-264244 from Nematostella and Branchiostoma, respectively. We previously cloned and characterized Tg-laforin and found that we could only obtain soluble recombinant Tg-laforin when we added a GST tag to the amino terminus of Tg-laforin [, and unpublished data]. Even with the addition of the GST tag, the majority of GST-Tg-laforin is insoluble, suggesting that the majority of the protein does not correctly fold in bacteria. Unlike Hs-laforin but similar to Tg-laforin, both Nv- and Bf-laforin were largely insoluble with a HIS6 epitope. Therefore, we generated bacterial constructs expressing GST-Nv-laforin-HIS6 and GST-Bf-laforin-HIS6, purified the recombinant proteins (Additional File 3), and biochemically characterized them.
Characteristic of all dual specificity phosphatases, human DSP VH1-related (VHR) and Hs-laforin exhibit phosphatase activity against the artificial substrate para-nitrophenylphosphate (p-NPP; Fig. 4A) [12, 50]. Both Bf- and Nv-laforin also utilized p-NPP as an artificial substrate (Fig. 4A). Bf-laforin exhibited a similar specific activity as Hs-laforin and SEX4, while the activity of Nv-laforin was lower and similar to Tg-laforin. The decreased activity of Nv-laforin is likely due to our difficulty in generating soluble Nv-laforin and suggests that some of the soluble Nv-laforin may be misfolded, similar to Tg-laforin. Even though the activity of Nv-laforin is substantially decreased, it does exhibit phosphatase activity and therefore it is a phosphatase. DSPs act by forming a phosphoenzyme intermediate after nuleophilic attack of the phosphorus atom of the substrate by a cysteine residue that is conserved in all DSPs in their signature motif, HCxxGxxRS (CX5R) . Mutation of this cysteine renders DSPs catalytically inactive. Therefore, we generated cys/ser (C/S) mutations in Bf- and Nv-laforin to test if their activity was dependent on this cysteine. As predicted, the Bf- and Nv-laforin C/S mutants displayed no activity against p-NPP (Fig. 4A). Enzymes generally have a preferred pH within to act, and DSPs are no different. We tested the phosphatase activity of Bf- and Nv-laforin at 0.5 unit increments from pH 5–8. While Hs-laforin has a maximal activity against p-NPP at pH 5, Bf-laforin had a maximal activity at pH 7 and Nv-laforin at pH 7.5 (Fig. 4B).
Since laforin is the only phosphatase in any Kingdom Animalia genome with a CBM, it is predicted to be the only phosphatase that binds carbohydrates. Bf- and Nv-laforin bound amylopectin to the same extent as Hs-laforin (Fig. 5). Conversely, VHR, which lacks a CBM, did not bind amylopectin (Fig. 5). Dixon and colleagues previously demonstrated that conserved tryptophan and lysine residues (marked with asterisks in Fig. 3) that participate in binding to the sugar are necessary for Hs-laforin to bind amylopectin (Fig. 5) . Accordingly, mutation of these corresponding residues in Bf-laforin (W29 and K69) and Nv-laforin (W31 and K76) also abolished their ability to bind amylopectin (Fig. 5).
Some DSPs dephosphorylate non-proteinaceous substrates, such as phosphatase and tensin homologue (PTEN), the myotubularin family, and Sac domain phosphatases that all dephosphorylate the inositol head group of phospholipids [52–56]. We recently discovered that laforin belongs to a unique class of enzymes that dephosphorylates glucans, namely glycogen and starch, and that other classes of phosphatases lack this activity [15, 21]. Amylopectin is the major component of plant starch and contains detectable amounts of phosphate [57, 58]. Therefore, we tested if Bf- and Nv-laforin could liberate phosphate from amylopectin. Similar to SEX4 and Hs-laforin, Bf- and Nv-laforin liberated phosphate from amylopectin, whereas VHR did not hydrolyze phosphate from amylopectin (Fig. 6A). The activity of Bf-laforin was comparable to the activity of SEX4, and the activity of Nv- and Tg-laforin were comparable. Similar to the p-NPP data, the activity of Bf- and Nv-laforin against amylopectin was also pH dependent (Fig. 6B).
Bf- and Nv-laforin possess the same three in vitro biochemical properties as Hs-laforin: both utilize p-NPP as an artificial substrate, bind amylopectin, and liberate phosphate from amylopectin. Additionally, the invertebrate laforin orthologs contain the critical signature primary amino acids of both a CBM20 and DSP, and they possess the same predicted secondary structure as Hs-laforin. Thus, our bioinformatics searches for a protein containing a CBM and DSP correctly predicted the proteins biochemical properties and we identified novel laforin orthologs. Our finding of laforin orthologs in two invertebrate genomes reinforces the global function of this protein and yields insights into the evolution of this gene family.
Evolutionary lineage of glucan phosphatases
As discussed above, we previously reported that laforin is not confined to vertebrate genomes, but it is also conserved in five protozoan genomes . The gene encoding laforin is conserved in species as divergent as humans and red algae, but it is absent in the vast majority of protozoan and invertebrate genomes. SEX4 is conserved in diverse members of Archaeplastida/Kingdom Plantae and is necessary for proper starch metabolism in Arabidopsis [15, 19, 20]. These findings suggest that laforin and SEX4 are ancient proteins that regulate an aspect of energy metabolism conserved in multiple kingdoms, namely the dephosphorylation of glycogen and starch.
We previously postulated that throughout evolution organisms maintained or lost laforin depending on their "need" to manage insoluble glucans . We suggested that protists with laforin maintained it to manage insoluble glucans as an energy source . Similarly, vertebrates maintained laforin because of their "need" to combat Lafora body accumulation and used this reasoning to explain why the genome of most metazoans (i.e. animals) lack laforin . However, it is also possible that vertebrate genomes have laforin as a result of horizontal gene transfer (HGT) from a protist.
To further investigate the evolutionary heritage of laforin and SEX4 we generated a phylogeny of all laforin and SEX4 orthologs. We identified full-length laforin orthologs in fifteen vertebrate genomes (encompassing all five classes), two invertebrate genomes, and six protozoan genomes (Fig. 7A). Additionally, we found multiple laforin paralogs in the genomes of B. floridae, T. thermophila, and P. tetraurelia. The laforin paralogs have an array of intron-exon numbers and boundaries, from a single exon to similar numbers (4 exons) and boundaries as Hs-laforin to as many as eight exons (Fig. 3C & Additional File 4). Gene duplication and intron gain and loss are all indicative of increased molecular evolution, suggesting that the laforin locus in these organisms has experienced increased evolutionary pressures. Among the protists, the Apicomplexa laforin orthologs rooted much closer to the invertebrates and vertebrates than did the Ciliate laforin orthologs (Fig. 7A). The Apicomplexa genomes all contain a single ortholog, while the two Ciliates both contain three. Both of these results argue for an increased rate of evolutionary drift in the Ciliates at the laforin locus. The alveolates that have laforin (see Fig. 1C) all contain at least four exons and three introns, thus agreeing with reports from the Koonin laboratory demonstrating increased intron-rich genes in alveolates .
In searching for SEX4 orthologs, we identified full-length orthologs in fourteen genomes, encompassing trees, land plants, a moss (Physcomitrella patens), and a single-cell green alga (Fig. 7B). In addition, we identified several partial cDNA or protein hits of SEX4 orthologs in other Archaeplastida (data not shown). These results demonstrate that SEX4 is conserved in all branches of Archaeplastida/Kingdom Plantae and highlight the importance of this glucan phosphatase throughout Archaeplastida.
Our finding of laforin in two invertebrate genomes raises questions regarding the evolutionary lineage of laforin in metazoans/animals. It is possible that the unique evolutionary lineage of laforin was a result of HGT from a protozoan or its ancestor. If so, this event occurred earlier than the radiation of metazoans because laforin is conserved in two invertebrate genomes, including the Cnidarian Nematostella.
An alternative hypothesis, and one that we favour, postulates that in non-protozoan genomes the absence or presence of laforin was determined by rates of molecular evolution and the need to combat insoluble glucans, while in protists conservation of laforin is determined by the three criteria previously presented and discussed . This hypothesis seems likely given recent reports showing the rate of molecular evolution in Branchiostoma and Nematostella is similar to that of vertebrates and the rate is much higher in other invertebrates, as discussed above (Table 1).
This hypothesis calls into question why laforin has been conserved. Invertebrates may not need laforin because they have significantly shorter lifespans than vertebrates. In support of this thought, the only cellular pathology observed in LD patients is neuronal apoptosis . Since neurons live longer than most all other cell types, it seems plausible that invertebrates may be more like skin cells (or other cell types with shorter lifespans); they accumulate LBs but not to a detrimental state. Thus, laforin may represent a vestigial gene or perhaps a pseudogene in Nematostella and Branchiostoma.
Alternatively, Nematostella and Branchiostoma may have laforin for a purpose. Vertebrates do not utilize insoluble glucans as an energy source, but they do "combat" the accumulation of insoluble glucans, in the form of detrimental LBs. We know that many, if not all, vertebrate species suffer from LD (including, canines, felines, cattle, and birds) [60–64]. It is possible that Nematostella and Branchiostoma also have laforin in order to combat LBs.
Lastly, Nematostella and Branchiostoma may have laforin because their genomes have not evolved as rapidly as other invertebrates, as has been recently demonstrated, and thus still have/need laforin [42, 44]. If this is the case, other invertebrates (e.g flies and worms) may not need laforin because they have evolved a separate means to deal with LB-like accumulations.
Regardless of what has driven the evolutionary lineage of laforin, these results define the boundaries of glucan phosphatase conservation. These findings coupled with our previous work establish the conservation of laforin and SEX4 in evolutionary niches from protozoans to plants to algae to vertebrates and now invertebrates. Notably, laforin and SEX4 are absent in bacteria and archaea. While these groups do contain each domain that is found in glucan phosphatases (i.e. a phosphatase domain and carbohydrate binding domain), no protein in their genomes contains both. Given the completeness of bacterial genomes, it is unlikely that a glucan phosphatase exists in bacteria. Therefore, we suspect that we have identified the complete evolutionary lineage of the glucan phosphatases laforin and SEX4. The conservation of laforin across evolutionary niches, coupled with what appears to be complete conservation of SEX4 throughout all Archaeplastida/Kingdom Plantae demonstrate that phosphorylation/dephosphorylation of glucans is pervasive throughout nature.
Plasmids and Proteins
Wild type and C/S Hs-laforin in pET21a (Novagen, San Diego, CA) for use in bacterial expression were described previously [13, 65]. Recombinant HIS-tagged VHR cloning and purification have been previously described . The complete open reading frame of Bf-laforin-264224 was amplified from cDNA provided by the Branchiostoma floridea Gene Collection . The complete open reading frame of Nv-laforin was amplified from Nematostella DNA provided by Dr. Mark Q. Martindale. Bf- and Nv-laforin were cloned into pET-GSTX and pET21a, respectively . Mutations were introduced using QuickChange (Stratagene). Recombinant GST- and His-tagged proteins were expressed in Escherichia coli BL21 (DE3) CodonPlus RIL cells (Stratagene, La Jolla, CA) and purified using Ni2+-agarose (Qiagen, Germany) and/or glutathione-agarose affinity chromatography steps as described previously .
Phosphatase Activity Assays
Hydrolysis of para-nitrophenylphosphate (p-NPP) was performed in 50 μl reactions containing 1X phosphate buffer (0.1 M sodium acetate, 0.05 M bis-Tris, 0.05 M Tris-HCl, 2 mM dithiothreitol, at the appropriate pH), 50 mM pNPP, and 100–500 ng of enzyme at 37°C for 5–30 minutes. The reaction was terminated by the addition of 200 μl of 0.25 M NaOH and absorbance was measured at 410 nm. We tested the specific activity of each enzyme at pH 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, and 8.0. Malachite green assays were performed as described  with the following modifications: 1X phosphate buffer, 100–500 ng of enzyme, and ≈45 μg of amylopectin in a final volume of 20 μl. The reaction was stopped by the addition of 20 μl of 0.1 M N-ethylmaleimide and 80 μl of malachite green reagent. Absorbance was measured after 30 minutes at 620 nm. We tested the specific activity of each enzyme at the same pH units as above.
Carbohydrate binding Assay
Carbohydrate binding assays were done similarly as described previously . Briefly, 50 mg of amylopectin was dissolved in 400 μl of ethanol, followed by the addition of 1 ml of water and 1 ml of 2 M NaOH, 2 ml of water was added, pH was adjusted to 6.5, and the total volume was brought to 10 ml. 1 ml of 5 mg/ml amylopectin was centrifuged at 50 K for 1.5 hours, the pellet was resuspended in 0.5 ml of buffer (50 mM Tris, pH7.5, 150 mM NaCl, 0.1% β-mercaptoethanol) with protease inhibitors, 0.5 μg of recombinant protein was added, the tube was rotated at 4°C for 1 hour, a second centrifugation was preformed at 50 K for 1.5 hours, the proteins in the supernatant were precipitated with acetone, and the pellet was resuspended in Western loading dye. Potato amylopectin was purchased from Sigma (St. Louis, MO). Recombinant proteins were detected with α-HIS-horeseradish peroxidase (HRP) antibody (Santa Cruz) and SuperSignal West Pico (Pierce).
Search strategy, sequence alignment, and phylogenetic analyses
The sequences of laforin and SEX4 orthologs were obtained by performing tBLASTn searches using the GenBank "dbEST" database or BLASTp and PSI-BLAST  searches using GenBank "eukaryote genome" and "non-redundant" (nr) databases, the Cyanidioschyzon merolae genome project, Department of Energy Joint Genome Institute Resource, The Institute for Genomic Research (TIGR), ToxoDB, GeneDB, Genoscope, UCSC Genome Browser, Tetrahymena Genome Database, and multiple organism specific databases. Accession numbers for small subunit (SSU) ribosomal RNA (rRNA), SEX4 orthologs, and laforin orthologs are listed in Additional File 5, 6, and 8, respectively. The web address for each database is listed in Additional File 4. A list of each genome that we investigated and a reason why an organism's genome lacks laforin is listed in Additional File 7. Amino-acid sequences of laforin orthologs were aligned by ClustalW  and refined manually using MacVector. SSU rRNA sequences were obtained by performing BLASTn using GenBank from "all organisms" and "nr" databases and accession numbers are listed in Additional File 5. Phylogenetic trees were generated from a ClustalW  multiple sequence alignment using PROTDIST and FITCH from the PHYLIP 3.65 software package and displayed utilizing HYPERTREE 1.0.0 .
Berkovic SF, Andermann F, Carpenter S, Wolfe LS: Progressive myoclonus epilepsies: specific causes and diagnosis. N Engl J Med. 1986, 315 (5): 296-305.
Berkovic SF, Cochius J, Andermann E, Andermann F: Progressive myoclonus epilepsies: clinical and genetic aspects. Epilepsia. 1993, 34 (Suppl 3): S19-30.
Minassian BA: Lafora's disease: towards a clinical, pathologic, and molecular synthesis. Pediatr Neurol. 2001, 25 (1): 21-29. 10.1016/S0887-8994(00)00276-9.
Van Heycop Ten Ham MW: Lafora disease, a form of progressive myoclonus epilepsy. Handbook of Clinical neurology. Edited by: Vinken PJ, Bryun GW. 1975, Holland, Amsterdam: North Holland Publishing Company, 15: 382-422.
Lafora G, Glick B: Beitrag zur histopathologie der myoklonischen epilepsie. Z Ges Neurol Psychiatr. 1911, 6: 1-14. 10.1007/BF02863929.
Yokoi S, Austin J, Witmer F, Sakai M: Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases. Arch Neurol. 1968, 19 (1): 15-33.
Sakai M, Austin J, Witmer F, Trueb L: Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology. 1970, 20 (2): 160-176.
Yokoi S, Austin J, Witmer F: Isolation and characterization of Lafora bodies in two cases of myoclonus epilepsy. Journal of Neuropathology and Experimental Neurology. 1967, 26 (1): 125-127.
Minassian BA, Lee JR, Herbrick JA, Huizenga J, Soder S, Mungall AJ, Dunham I, Gardner R, Fong CY, Carpenter S, et al: Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet. 1998, 20 (2): 171-174. 10.1038/2470.
Serratosa JM, Gomez-Garre P, Gallardo ME, Anta B, de Bernabe DB, Lindhout D, Augustijn PB, Tassinari CA, Malafosse RM, Topcu M, et al: A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet. 1999, 8 (2): 345-352. 10.1093/hmg/8.2.345.
Yuvaniyama J, Denu JM, Dixon JE, Saper MA: Crystal Structure of the Dual Specificity Protein Phosphatase VHR. Science. 1996, 272: 1328-1331. 10.1126/science.272.5266.1328.
Ganesh S, Agarwala KL, Ueda K, Akagi T, Shoda K, Usui T, Hashikawa T, Osada H, Delgado-Escueta AV, Yamakawa K: Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. Hum Mol Genet. 2000, 9 (15): 2251-2261.
Wang J, Stuckey JA, Wishart MJ, Dixon JE: A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen. J Biol Chem. 2002, 277 (4): 2377-2380. 10.1074/jbc.C100686200.
Ganesh S, Tsurutani N, Suzuki T, Hoshii Y, Ishihara T, Delgado-Escueta AV, Yamakawa K: The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies. Biochem Biophys Res Commun. 2004, 313 (4): 1101-1109. 10.1016/j.bbrc.2003.12.043.
Gentry MS, Dowen RH, Worby CA, Mattoo S, Ecker JR, Dixon JE: The phosphatase laforin crosses evolutionary boundaries and links carbohydrate metabolism to neuronal disease. J Cell Biol. 2007, 178 (3): 477-488. 10.1083/jcb.200704094.
Coppin A, Dzierszinski F, Legrand S, Mortuaire M, Ferguson D, Tomavo S: Developmentally regulated biosynthesis of carbohydrate and storage polysaccharide during differentiation and tissue cyst formation in Toxoplasma gondii. Biochimie. 2003, 85 (3–4): 353-10.1016/S0300-9084(03)00076-2.
Coppin A, Varré J, Lienard L, Dauvillée D, Guérardel Y, Soyer-Gobillard M, Buléon A, Ball S, Stanislas Tomavo: Evolution of Plant-Like Crystalline Storage Polysaccharide in the Protozoan Parasite Toxoplasma gondii Argues for a Red Alga Ancestry. Journal of Molecular Evolution. 2005, 60 (2): 257-267. 10.1007/s00239-004-0185-6.
Guérardel Y, Leleu D, Coppin A, Liénard L, Slomianny C, Strecker G, Ball S, Tomavo S: Amylopectin biogenesis and characterization in the protozoan parasite Toxoplasma gondii, the intracellular development of which is restricted in the HepG2 cell line. Microbes and Infection. 2005, 7 (1): 41-48. 10.1016/j.micinf.2004.09.007.
Niittyla T, Comparot-Moss S, Lue W-L, Messerli G, Trevisan M, Seymour MDJ, Gatehouse JA, Villadsen D, Smith SM, Chen J, et al: Similar protein phosphatases control starch metabolism in plants and glycogen metabolism in mammals. J Biol Chem. 2006, 281 (17): 11815-11818. 10.1074/jbc.M600519200.
Sokolov LN, Dominguez-Solis JR, Allary AL, Buchanan BB, Luan S: A redox-regulated chloroplast protein phosphatase binds to starch diurnally and functions in its accumulation. Proc Natl Acad Sci USA. 2006, 103 (25): 9732-9737. 10.1073/pnas.0603329103.
Worby CA, Gentry MS, Dixon JE: Laforin: A dual specificity phosphatase that dephosphorylates complex carbohydrates. J Biol Chem. 2006, 281 (41): 30412-30418. 10.1074/jbc.M606117200.
Kotting O, Santelia D, Edner C, Eicke S, Marthaler T, Gentry MS, Comparot-Moss S, Chen J, Smith AM, Steup M, et al: STARCH-EXCESS4 Is a Laforin-Like Phosphoglucan Phosphatase Required for Starch Degradation in Arabidopsis thaliana. Plant Cell. 2009, 21 (1): 334-346. 10.1105/tpc.108.064360.
Tagliabracci VS, Turnbull J, Wang W, Girard JM, Zhao X, Skurat AV, Delgado-Escueta AV, Minassian BA, Depaoli-Roach AA, Roach PJ: Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Proc Natl Acad Sci USA. 2007, 104 (49): 19262-19266. 10.1073/pnas.0707952104.
Tagliabracci VS, Girard JM, Segvich D, Meyer C, Turnbull J, Zhao X, Minassian BA, Depaoli-Roach AA, Roach PJ: Abnormal metabolism of glycogen phosphate as a cause for lafora disease. J Biol Chem. 2008, 283 (49): 33816-33825. 10.1074/jbc.M807428200.
Boraston AB, Bolam DN, Gilbert HJ, Daview GJ: Carbohydrate-binding modules: fine-tuning polysaccharide recognition. The Biochemical Journal. 2004, 382: 769-781. 10.1042/BJ20040892.
Coutinho PM, Henrissat B: Carbohydrate-active enzymes: an integrated database approach. Recent Advances in Carbohydrate Bioengineering. Edited by: Gilbert HJGD, Henrissat B, Svensson B. 1999, Cambridge: The Royal Society of Chemistry, 3-12.
Rodriguez-Sanoja R, Oviedo N, Sanchez S: Microbial starch-binding domain. Curr Opin Microbiol. 2005, 8 (3): 260-267. 10.1016/j.mib.2005.04.013.
Machovic M, Janecek S: Starch-binding domains in the post-genome era. Cell Mol Life Sci. 2006, 63 (23): 2710-2724. 10.1007/s00018-006-6246-9.
Machovic M, Svensson B, MacGregor EA, Janecek S: A new clan of CBM families based on bioinformatics of starch-binding domains from families CBM20 and CBM21. FEBS J. 2005, 272 (21): 5497-5513. 10.1111/j.1742-4658.2005.04942.x.
Svensson B, Jespersen H, Sierks MR, MacGregor EA: Sequence homology between putative raw-starch binding domains from different starch-degrading enzymes. Biochem J. 1989, 264 (1): 309-311.
Janecek S, Sevcik J: The evolution of starch-binding domain. FEBS Lett. 1999, 456 (1): 119-125. 10.1016/S0014-5793(99)00919-9.
Speer CA, Dubey JP, McAllister MM, Blixt JA: Comparative ultrastructure of tachyzoites, bradyzoites, and tissue cysts of Neospora caninum and Toxoplasma gondii. Int J Parasitol. 1999, 29 (10): 1509-1519. 10.1016/S0020-7519(99)00132-0.
Embley TM, Martin W: Eukaryotic evolution, changes and challenges. Nature. 2006, 440 (7084): 623-630. 10.1038/nature04546.
Cavalier-Smith T: Principles of Protein and LIpid Targeting in Secondary Symbiogenesis: Euglenoid, Dinoflagellatae, and Sporozoan Plastid Origins and the Eukaryote Family Tree. The Journal of Eukaryotic Microbiology. 1999, 46 (4): 347-366. 10.1111/j.1550-7408.1999.tb04614.x.
Cavalier-Smith T: Only six kingdoms of life. Proc Biol Sci. 2004, 271 (1545): 1251-1262. 10.1098/rspb.2004.2705.
Dubey JP: Neosporosis – the first decade of research. Int J Parasitol. 1999, 29 (10): 1485-1488. 10.1016/S0020-7519(99)00134-4.
Dubey JP, Carpenter JL, Speer CA, Topper MJ, Uggla A: Newly recognized fatal protozoan disease of dogs. J Am Vet Med Assoc. 1988, 192 (9): 1269-1285.
Animals. Metazoa. [http://tolweb.org/Animals/2374/2002.01.01]
Peterson KJ, Butterfield NJ: Origin of the Eumetazoa: testing ecological predictions of molecular clocks against the Proterozoic fossil record. Proc Natl Acad Sci USA. 2005, 102 (27): 9547-9552. 10.1073/pnas.0503660102.
Peterson KJ, Lyons JB, Nowak KS, Takacs CM, Wargo MJ, McPeek MA: Estimating metazoan divergence times with a molecular clock. Proc Natl Acad Sci USA. 2004, 101 (17): 6536-6541. 10.1073/pnas.0401670101.
King N, Westbrook MJ, Young SL, Kuo A, Abedin M, Chapman J, Fairclough S, Hellsten U, Isogai Y, Letunic I, et al: The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans. Nature. 2008, 451 (7180): 783-788. 10.1038/nature06617.
Putnam NH, Butts T, Ferrier DE, Furlong RF, Hellsten U, Kawashima T, Robinson-Rechavi M, Shoguchi E, Terry A, Yu JK, et al: The amphioxus genome and the evolution of the chordate karyotype. Nature. 2008, 453 (7198): 1064-1071. 10.1038/nature06967.
Srivastava M, Begovic E, Chapman J, Putnam NH, Hellsten U, Kawashima T, Kuo A, Mitros T, Salamov A, Carpenter ML, et al: The Trichoplax genome and the nature of placozoans. Nature. 2008, 454 (7207): 955-960. 10.1038/nature07191.
Putnam NH, Srivastava M, Hellsten U, Dirks B, Chapman J, Salamov A, Terry A, Shapiro H, Lindquist E, Kapitonov VV, et al: Sea anemone genome reveals ancestral eumetazoan gene repertoire and genomic organization. Science. 2007, 317 (5834): 86-94. 10.1126/science.1139158.
Holland LZ, Albalat R, Azumi K, Benito-Gutierrez E, Blow MJ, Bronner-Fraser M, Brunet F, Butts T, Candiani S, Dishaw LJ, et al: The amphioxus genome illuminates vertebrate origins and cephalochordate biology. Genome Res. 2008, 18 (7): 1100-1111. 10.1101/gr.073676.107.
Kortschak RD, Samuel G, Saint R, Miller DJ: EST analysis of the cnidarian Acropora millepora reveals extensive gene loss and rapid sequence divergence in the model invertebrates. Curr Biol. 2003, 13 (24): 2190-2195. 10.1016/j.cub.2003.11.030.
Technau U, Rudd S, Maxwell P, Gordon PM, Saina M, Grasso LC, Hayward DC, Sensen CW, Saint R, Holstein TW, et al: Maintenance of ancestral complexity and non-metazoan genes in two basal cnidarians. Trends Genet. 2005, 21 (12): 633-639. 10.1016/j.tig.2005.09.007.
Raible F, Tessmar-Raible K, Osoegawa K, Wincker P, Jubin C, Balavoine G, Ferrier D, Benes V, de Jong P, Weissenbach J, et al: Vertebrate-type intron-rich genes in the marine annelid Platynereis dumerilii. Science. 2005, 310 (5752): 1325-1326. 10.1126/science.1119089.
Miller DJ, Ball EE: Cryptic complexity captured: the Nematostella genome reveals its secrets. Trends Genet. 2008, 24 (1): 1-4. 10.1016/j.tig.2007.10.002.
Zhou G, Denu JM, Wu L, Dixon JE: The catalytic role of Cys124 in the dual specificity phosphatase VHR. J Biol Chem. 1994, 269 (45): 28084-28090.
Denu JM, Stuckey JA, Saper MA, Dixon JE: Form and Function in Protein Dephosphorylation. Cell. 1996, 87 (3): 361-10.1016/S0092-8674(00)81356-2.
Guo S, Stolz LE, Lemrow SM, York JD: SAC1-like domains of yeast SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases. J Biol Chem. 1999, 274 (19): 12990-12995. 10.1074/jbc.274.19.12990.
Hughes WE, Cooke FT, Parker PJ: Sac phosphatase domain proteins. Biochem J. 2000, 350 (Pt 2): 337-352. 10.1042/0264-6021:3500337.
Maehama T, Dixon JE: The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate. J Biol Chem. 1998, 273 (22): 13375-13378. 10.1074/jbc.273.22.13375.
Taylor GS, Maehama T, Dixon JE: Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci USA. 2000, 97 (16): 8910-8915. 10.1073/pnas.160255697.
Robinson FL, Dixon JE: Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol. 2006, 16 (8): 403-412. 10.1016/j.tcb.2006.06.001.
Blennow A, Nielsen TH, Baunsgaard L, Mikkelsen R, Engelsen SB: Starch phosphorylation: a new front line in starch research. Trends Plant Sci. 2002, 7 (10): 445-450. 10.1016/S1360-1385(02)02332-4.
Yu TS, Kofler H, Hausler RE, Hille D, Flugge UI, Zeeman SC, Smith AM, Kossmann J, Lloyd J, Ritte G, et al: The Arabidopsis sex1 mutant is defective in the R1 protein, a general regulator of starch degradation in plants, and not in the chloroplast hexose transporter. Plant Cell. 2001, 13 (8): 1907-1918. 10.1105/tpc.13.8.1907.
Csuros M, Rogozin IB, Koonin EV: Extremely intron-rich genes in the alveolate ancestors inferred with a flexible maximum-likelihood approach. Mol Biol Evol. 2008, 25 (5): 903-911. 10.1093/molbev/msn039.
Lohi H, Young EJ, Fitzmaurice SN, Rusbridge C, Chan EM, Vervoort M, Turnbull J, Zhao XC, Ianzano L, Paterson AD, et al: Expanded repeat in canine epilepsy. Science. 2005, 307 (5706): 81-10.1126/science.1102832.
Simmons MM: Lafora disease in the cow?. J Comp Pathol. 1994, 110 (4): 389-401. 10.1016/S0021-9975(08)80316-7.
Loupal G: [A storage disease in a parakeet (Nymphicus hollandicus) morphologically similar to the systemic myoclonic disease (Lafora disease) in man and dog]. Zentralbl Veterinarmed A. 1985, 32 (7): 502-511.
Suzuki Y, Kamiya S, Ohta K, Suu S: Lafora-like bodies in a cat. Case report suggestive of glycogen metabolism disturbances. Acta Neuropathol. 1979, 48 (1): 55-58. 10.1007/BF00691791.
Cavanagh JB: Corpora-amylacea and the family of polyglucosan diseases. Brain Res Brain Res Rev. 1999, 29 (2–3): 265-295. 10.1016/S0165-0173(99)00003-X.
Worby CA, Gentry MS, Dixon JE: Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG). J Biol Chem. 2008, 283 (7): 4069-4076. 10.1074/jbc.M708712200.
Yu JK, Wang MC, Shin IT, Kohara Y, Holland LZ, Satoh N, Satou Y: A cDNA resource for the cephalochordate amphioxus Branchiostoma floridae. Dev Genes Evol. 2008
Taylor GS, Liu Y, Baskerville C, Charbonneau H: The activity of Cdc14p, an oligomeric dual specificity protein phosphatase from Saccharomyces cerevisiae, is required for cell cycle progression. J Biol Chem. 1997, 272 (38): 24054-24063. 10.1074/jbc.272.38.24054.
Gentry MS, Worby CA, Dixon JE: Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc Natl Acad Sci USA. 2005, 102 (24): 8501-8506. 10.1073/pnas.0503285102.
Harder KW, Owen P, Wong LK, Aebersold R, Clark-Lewis I, Jirik FR: Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides. Biochemical Journal. 1994, 298: 395-401.
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25 (17): 3389-3402. 10.1093/nar/25.17.3389.
Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res. 1994, 22 (22): 4673-4680. 10.1093/nar/22.22.4673.
Bingham J, Sudarsanam S: Visualizing large hierarchical clusters in hyperbolic space. Bioinformatics. 2000, 16 (7): 660-661. 10.1093/bioinformatics/16.7.660.
Adl SM, AG Simpson, MA Farmer, RA Andersen, OR Anderson, JR Barta, SS Bowser, G Brugerolle, RA Fensome, et al: The new higher level classification of eukaryotes with emphasis on the taxonomy of protists. The Journal of Eukaryotic Microbiology. 2005, 52: 399-451. 10.1111/j.1550-7408.2005.00053.x.
We thank Drs. Doug Andres, Seema Mattoo, and Carolyn Worby for insightful discussions; Dr. Yutaka Satou and the Branchiostoma floridea Gene Collection for B. floridea cDNA; and Drs. Mark Q. Martindale and John R. Finnerty for N. vectensis DNA. This work was supported by National Institutes of Health grants 5R00NS061803 and 5P20RR0202171 (to M.S.G.) and University of Kentucky College of Medicine start-up funds.
MSG initiated the study, cloned the various laforin orthologs, designed the experiments, performed experiments, performed all evolutionary analyses, compiled and analyzed data, generated figures, directed the project, and wrote the manuscript. RMP subcloned laforin orthologs into vectors, performed in vitro biochemical assays, assisted with interpretation of results, and assisted with writing that paper and generating figures. Both authors read and approved the final manuscript.
Electronic supplementary material
Additional file 1: Table of Non-NCBI databases used in this study. The non-NCBI databases used to search for laforin orthologs are listed in blue and the organisms' genome in each database is listed in black. Many of the databases were found by performing a Google search of the organisms genus name and "genome." (PDF 33 KB)
Additional file 3: Purification of recombinant GST-Bf-laforin and GST-Nv-laforin. A, GST-Nv-laforin-HIS6 was purified from soluble E. coli lysate via Ni2+-agarose affinity chromatography. B, GST-Bf-laforin-HIS6 was purified from soluble E. coli lysate via Ni2+-agarose affinity chromatography. U, uninduced; I, induced; PL, post-lysis; P, pellet (insoluble) fraction; S, soluble fraction; NB, not bound to beads; Bds, bound to HIS beads; HIS E, HIS eluate; GST E, GST eluate. (PNG 5 MB)
Additional file 4: Intron-exon numbers and boundaries of laforin genes. Predicted intron-exon boundaries for the genes encoding Hs-, Tg-, Nc-, Et-, Cm-, Tt- and Pt-laforin. The coding region that encodes the CBM is highlighted in red, the DSP in blue, and the rest is in gray. Accession numbers are listed in Additional File 8. (PDF 265 KB)
Additional file 5: Table of small subunit (SSU) ribosomal RNA (rRNA) accession numbers. Listed on the left are the organisms from the phylogeny in Figure 1 and on the right are the accession numbers for the SSU rRNA genes. Each of the accession numbers are from NCBI Genbank unless otherwise noted. (PDF 52 KB)
Additional file 7: Table of genomes investigated for the presence of laforin. The genome of each organism was searched for laforin and/or SEX4 using the appropriate database (Additional File 4). If laforin was absent an extensive literature search was performed on the organism to determine which of the three criteria it lacked: red algal descent, mitochondrion, and/or floridean starch/LBs. If the organism lacked laforin, then at least one of the three criteria that it lacks is presented beside its name. The organism name of genomes containing laforin are bold and in green. The organism name of genomes that are nearing completion and that contain laforin based on our predictions are bold and in red. The phrase "incomplete genome, has laforin" refers to organisms with incomplete genomes, but where a partial CBM and DSP corresponding to laforin was found. Highlighted in yellow are organisms found in this study to contain laforin. Organism classification is based on widely accepted taxonomy classifications . (PDF 77 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Gentry, M.S., Pace, R.M. Conservation of the glucan phosphatase laforin is linked to rates of molecular evolution and the glucan metabolism of the organism. BMC Evol Biol 9, 138 (2009) doi:10.1186/1471-2148-9-138
- Carbohydrate Binding Module
- Intron Loss
- Dual Specificity Phosphatase
- Lafora Disease